<i>Vital Signs:</i> Hepatitis C Treatment Among Insured Adults — United States, 2019

Vital Signs: Hepatitis C Treatment Among Insured Adults — United States, 2019–2020

Published:2022-08-12 Issue:32 Volume:71 Page:1011-1017
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Thompson William W.,Symum Hasan,Sandul Amy,Gupta Neil,Patel Priti,Nelson Noele,Mermin Jonathan,Wester Carolyn,

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference20 articles.

1. Estimating prevalence of hepatitis C virus infection in the United States, 2013–2016.;Hofmeister;Hepatology,2019

2. CDC. Viral hepatitis surveillance 2019. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. Accessed July 24, 2022. https://www.cdc.gov/hepatitis/statistics/2019surveillance/index.htm

3. Pathogenesis, natural history, treatment, and prevention of hepatitis C.;Liang;Ann Intern Med,2000

4. American Association for the Study of Liver Diseases; the Infectious Disease Society of America. Recommendations for testing, managing, and treating hepatitis C. Alexandria, VA; Arlington, VA: American Association for the Study of Liver Diseases and the Infectious Disease Society of America; 2022. Accessed May 05, 2022. http://www.hcvguidelines.org

5. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.;van der Meer;JAMA,2012

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma national burden across different geographical regions in the United States between 2001 and 2020;World Journal of Methodology;2024-12-20

2. IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis C;Journal of Infection;2024-11

3. Closing the Gaps in Hepatitis C Knowledge Among Internal Medicine Residents in the United States;American Journal of Medicine Open;2024-08

4. Impact of a Pharmacist-Led HCV Treatment Program at a Federally Qualified Health Center;Pharmacy;2024-07-24

5. Medicaid Expansion and Restriction Policies for Hepatitis C Treatment;JAMA Network Open;2024-07-16